A new phase 3 trial evaluates whether trastuzumab deruxtecan (T-DXd) can improve invasive disease-free survival compared with trastuzumab emtansine (T-DM1) in patients with residual HER2-positive early...
Research examined if a magnetic resonance imaging technique could cut down the number of unnecessary breast biopsies in women with suspicious mammogram results.
Researchers evaluated the impact of a Mediterranean Diet with supplemented with extra-virgin olive oil on the rate of breast cancer onset in older women.
Physicians reviewing patient-facing screening guidance from major cancer centers may encounter recommendations that do not fully align with USPSTF standards. In a cross-sectional analysis, investigators...
